<DOC>
	<DOCNO>NCT01878123</DOCNO>
	<brief_summary>This Phase 1 , single-dose , placebo-controlled , dose-escalation , multi-center , first time human study AMP-110 adult subject rheumatoid arthritis .</brief_summary>
	<brief_title>Study Assess Safety , Tolerability , Pharmacokinetics AMP-110 Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Must able provide write informed consent Body mass index 18.5 35.0 kg/m2 Diagnosis Rheumatoid Arthritis accord 1987 revised American College Rheumatology ( ACR ) criteria Global Functional Class I , II , III accord ACR 1991 revise criterion Stable use &gt; /= 1 Disease Modifying Antirheumatic Drugs ( DMARD ) &gt; /= 4 week prior Day 0 , include : 1 . Methotrexate ( MTX ) 7.5 25 mg/week 2 . Hydroxychloroquine ( HCQ ) &lt; /= 400 mg/day 3 . Sulfasalazine ( SSZ ) 1,000 3,000 mg/day 4 . Leflunomide 5 20 mg/day 5 . Azathioprine 150 mg/day 2 mg/kg/day 6 . Combinations MTX , HCQ , and/or SSZ allow Prior Day 0 , use 1 . Abatacept 2 . Rituximab within 6 month 3 . Infliximab , Adalimumab , Certolizumab , Tocilizumab , Cyclosporine , Mycophenolate mofetil within 2 month 4 . Etanercept Anakinra within 28 day 5 . Immunoglobulin blood product within 28 day Evidence active recent infection include ongoing , chronic infectious disease chronic renal infection chronic chest infection bronchiectasis sinusitis History systemic autoimmune disease Rheumatoid Arthritis History allergic reaction protein therapeutic monoclonal antibody fusion protein History anaphylaxis allergic diathesis Clinically significant cardiac disease , include : unstable angina ; myocardial infarction within 6 month ; congestive heart failure ; arrhythmia require active therapy , exception clinically insignificant extrasystole , minor conduction abnormality ; history clinically significant abnormality electrocardiogram Evidence active latent tuberculosis Vaccination wtih live attenuated virus within 2 week prior Day 0 Evidence infection hepatitis B virus , hepatitis C virus , human immunodeficiency virus 1 2 , active infection hepatitis A Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Joint Diseases</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
	<keyword>Rheumatic Diseases</keyword>
	<keyword>Connective Tissue Diseases</keyword>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Antirheumatic agent</keyword>
</DOC>